正海生物：钙硅生物陶瓷骨修复材料产品注册工作已接近尾声，活性生物骨全年推广入院量稳步攀升且符合预期

Core Viewpoint - The company is nearing the completion of the registration process for its calcium silicate bioceramic bone repair materials, with expectations to achieve certification within 2025. The active biological bone product is showing steady market promotion and revenue contribution, with plans for increased market penetration and revenue growth in the future [1]. Group 1 - The registration work for the calcium silicate bioceramic bone repair materials is close to completion [1] - The company will continue to monitor the registration progress and fulfill its information disclosure obligations [1] - The annual promotion and hospital admission volume of the active biological bone product is steadily increasing and meets expectations [1] Group 2 - The company aims to enhance product market coverage and revenue contribution levels through continued efforts in product promotion [1]